Mobile Health Intervention for Young Adult Cancer Survivors
(mHealthAYA Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new phone and app-based program designed to help young adult cancer survivors feel more hopeful and improve their quality of life. It consists of two parts: one focuses on general health education, while the other uses an empirically supported protocol with skills and activities to boost hopeful thinking. The trial seeks participants diagnosed with cancer between ages 20-39, who have completed their main cancer treatments within the last three years, and have access to a smartphone. As an unphased trial, this study offers a unique opportunity for participants to contribute to innovative approaches that may enhance the well-being of future cancer survivors.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on a phone- and app-based intervention to promote hope among young adult cancer survivors.
What prior data suggests that this protocol is safe for young adult cancer survivors?
Research shows that treatments designed for young adult cancer survivors are generally safe. These treatments often include psychological support and behavior change strategies, which participants usually handle well. Studies on similar treatments have not identified major side effects, indicating that serious problems are rare or absent. The main goal is to improve mental health and quality of life, and research has shown these treatments can help. Since this approach uses proven methods like cognitive behavioral therapy and positive psychology, it is considered safe for participants.12345
Why are researchers excited about this trial?
Researchers are excited about this trial because it explores a unique mobile health intervention tailored for young adult cancer survivors, focusing on improving quality of life. Unlike traditional approaches that might rely heavily on medications or in-person therapy sessions, this intervention leverages an empirically supported protocol refined with evidence-based strategies. It incorporates elements of cognitive behavioral therapy and positive psychology, delivered through an 8-week curriculum that includes psychoeducation, skill-building, and self-monitoring. This innovative method aims to foster hopeful thinking and improve mental health and health behaviors, offering a potentially more accessible and personalized approach to survivor care.
What evidence suggests that this trial's treatments could be effective for young adult cancer survivors?
This trial compares two approaches for young adult cancer survivors. The intervention arm uses a new mobile health program aimed at increasing hope and improving quality of life. This program incorporates techniques from cognitive behavioral therapy and positive psychology, which have successfully improved mental health and life satisfaction. Although specific data for this program is not yet available, similar programs have helped young survivors manage symptoms and navigate life after cancer. The focus on encouraging hopeful thinking is new and could lead to better mental health and healthier habits over time. Meanwhile, the attention control arm provides health education based on American Cancer Society and NCI guidelines, focusing on maintaining a healthy weight, physical activity, and nutrition.12567
Who Is on the Research Team?
Carla J Berg, PhD
Principal Investigator
George Washington University
Are You a Good Fit for This Trial?
This trial is for young adults aged 20-39 who have been treated for stages I-IV cancer within the last three years. Participants should not have significant psychological disabilities, must understand English, and need to have a smartphone. They also must be willing to commit to an 8-week study that's delivered remotely.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo an 8-week phone- and app-based intervention to promote hope and mitigate life disruption caused by cancer diagnosis and treatment
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments of hope, quality of life, and health behaviors
What Are the Treatments Tested in This Trial?
Interventions
- Empirically Supported Protocol
- Health Education
Find a Clinic Near You
Who Is Running the Clinical Trial?
George Washington University
Lead Sponsor
National Cancer Institute (NCI)
Collaborator